INS and type 1 diabetes mellitus: In patients presenting with recent T1D onset, there are various interventions that may stop, or at least delay, pancreatic beta cell destruction; however, these therapies are unable to reverse the patient's lifelong dependency on insulin injections because beta cell proliferation and their capacity for regeneration are limited.